INBX
Price
$27.80
Change
+$0.18 (+0.65%)
Updated
Sep 3 closing price
Capitalization
402.69M
70 days until earnings call
STOK
Price
$19.77
Change
+$0.18 (+0.92%)
Updated
Sep 3 closing price
Capitalization
1.08B
68 days until earnings call
Interact to see
Advertisement

INBX vs STOK

Header iconINBX vs STOK Comparison
Open Charts INBX vs STOKBanner chart's image
Inhibrx Biosciences
Price$27.80
Change+$0.18 (+0.65%)
Volume$80.65K
Capitalization402.69M
Stoke Therapeutics
Price$19.77
Change+$0.18 (+0.92%)
Volume$1.37M
Capitalization1.08B
INBX vs STOK Comparison Chart in %
Loading...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INBX vs. STOK commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INBX is a Buy and STOK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (INBX: $27.80 vs. STOK: $19.77)
Brand notoriety: INBX and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INBX: 68% vs. STOK: 163%
Market capitalization -- INBX: $402.69M vs. STOK: $1.08B
INBX [@Biotechnology] is valued at $402.69M. STOK’s [@Biotechnology] market capitalization is $1.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INBX’s FA Score shows that 1 FA rating(s) are green whileSTOK’s FA Score has 1 green FA rating(s).

  • INBX’s FA Score: 1 green, 4 red.
  • STOK’s FA Score: 1 green, 4 red.
According to our system of comparison, STOK is a better buy in the long-term than INBX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INBX’s TA Score shows that 4 TA indicator(s) are bullish while STOK’s TA Score has 4 bullish TA indicator(s).

  • INBX’s TA Score: 4 bullish, 3 bearish.
  • STOK’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, INBX is a better buy in the short-term than STOK.

Price Growth

INBX (@Biotechnology) experienced а +1.46% price change this week, while STOK (@Biotechnology) price change was +2.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

INBX is expected to report earnings on Nov 13, 2025.

STOK is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STOK($1.08B) has a higher market cap than INBX($403M). STOK has higher P/E ratio than INBX: STOK (22.72) vs INBX (0.20). INBX (80.519) and STOK (79.238) have similar YTD gains . STOK has higher annual earnings (EBITDA): 42.3M vs. INBX (-155.08M). STOK has more cash in the bank: 248M vs. INBX (187M). STOK has less debt than INBX: STOK (2.3M) vs INBX (107M). STOK has higher revenues than INBX: STOK (200M) vs INBX (1.4M).
INBXSTOKINBX / STOK
Capitalization403M1.08B37%
EBITDA-155.08M42.3M-367%
Gain YTD80.51979.238102%
P/E Ratio0.2022.721%
Revenue1.4M200M1%
Total Cash187M248M75%
Total Debt107M2.3M4,660%
FUNDAMENTALS RATINGS
STOK: Fundamental Ratings
STOK
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
46
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INBXSTOK
RSI
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 15 days ago
86%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IARYX16.650.01
+0.06%
Invesco Real Estate Y
FZAOX34.95N/A
N/A
Fidelity Advisor Small Cap Z
SVACX6.44N/A
N/A
Federated Hermes Strategic Value Div C
CRARX10.36N/A
N/A
NYLI CBRE Real Estate Class I
CESGX11.87-0.01
-0.08%
Coho Relative Value ESG

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with COGT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
+0.65%
COGT - INBX
41%
Loosely correlated
+9.00%
ACET - INBX
38%
Loosely correlated
-0.60%
STOK - INBX
37%
Loosely correlated
+0.92%
IPSC - INBX
36%
Loosely correlated
-1.60%
ZYME - INBX
36%
Loosely correlated
+0.93%
More

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with IDYA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
+0.92%
IDYA - STOK
50%
Loosely correlated
+1.10%
QTTB - STOK
49%
Loosely correlated
N/A
SYRE - STOK
47%
Loosely correlated
+1.08%
IMNM - STOK
47%
Loosely correlated
+10.45%
DNLI - STOK
46%
Loosely correlated
-0.91%
More